Ignorer les liens de navigation
Qui sommes nous ? Référence-Recherche Pôle Formation Formation universitaire Formation continue E-Formation Formation en partenariat DPC Documentation & publications Service QRE Sang & Transfusion sanguine Europe & International
INTS in English INTS in English
 
 


Votre recherche : [La BTT] AUTEUR égal Goodrich R
14 résultat(s)


 
BTT Cookson P, Thomas S, Marschner S, Goodrich R, Cardigan R. In vitro quality of single-donor platelets treated with riboflavin and ultraviolet light and stored in platelet storage medium for up to 8 days. Transfusion. 2012;52:983-994.
Thèmes : Produits sanguins plaquettaires ; Inactivation des pathogènes ; maj-2012-11
Notice PubMed
BTT Stormer M, Arroyo A, Brachert J, Carrero H, Devine D, Epstein JS, Gabriel C, Gelber C, Goodrich R, Hanschmann KM, Heath DG, Jacobs MR, Keil S, De Korte D, Lambrecht B, Lee CK, Marcelis J, Marschner S, McDonald C, McGuane S, McKee M, Muller TH, Muthivhi T, Pettersson A, Radziwon P, Ramirez-Arcos S, Reesink HW, Rojo J, Rood I, Schmidt M, Schneider CK, Seifried E, Sicker U, Wendel S, Wood EM, Yomtovian RA, Montag T. Establishment of the first international repository for transfusion-relevant bacteria reference strains: ISBT working party transfusion-transmitted infectious diseases (WP-TTID), subgroup on bacteria. Vox Sang. 2012;102:22-31.
Thèmes : Bactéries ; maj-2012-11
Notice PubMed
BTT Atreya C, Nakhasi H, Mied P, Epstein J, Hughes J, Gwinn M, Kleinman S, Dodd R, Stramer S, Walderhaug M, Ganz P, Goodrich R, Tibbetts C, Asher D. FDA workshop on emerging infectious diseases: evaluating emerging infectious diseases (EIDs) for transfusion safety. Transfusion. 2011;51:1855-1871.
Thèmes : Epidémiologie ; maj-2012-02
Notice PubMed
BTT Galan AM, Lozano M, Molina P, Navalon F, Marschner S, Goodrich R, Escolar G. Impact of pathogen reduction technology and storage in platelet additive solutions on platelet function. Transfusion. 2011;51:808-815.
Thèmes : Produits sanguins plaquettaires ; Inactivation des pathogènes ; maj-2011-11
BTT Marschner S, Goodrich R. Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light. Transfus Med Hemother. 2011;38:8-18.
Thèmes : Produits sanguins plaquettaires ; Inactivation des pathogènes ; maj-2012-02
Notice PubMed
BTT Janetzko K, Hinz K, Marschner S, Goodrich R, Kluter H. Pathogen reduction technology (Mirasol) treated single-donor platelets resuspended in a mixture of autologous plasma and PAS. Vox Sang. 2009;97:234-239.
Thèmes : Produits sanguins plaquettaires ; Inactivation des pathogènes ; maj-2010-04
BTT Janetzko K, Hinz K, Marschner S, Goodrich R, Klüter H. Evaluation of different preparation procedures of pathogen reduction technology(Mirasol®)-treated platelets collected by plateletpheresis. Transfus Med Hemother. 2009;36:309-315.
Thèmes : Produits sanguins plaquettaires ; Inactivation des pathogènes ; maj-2010-04
BTT Cardo LJ, Salata J, Mendez J, Reddy H, Goodrich R. Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light. Transfus Apher Sci. 2007;37:131-137.
Thèmes : Parasites ; Inactivation des pathogènes ; maj-2008-04
BTT Rentas F, Harman R, Gomez C, Salata J, Childs J, Silva T, Lippert L, Montgomery J, Richards A, Chan C, Jiang J, Reddy H, Li J, Goodrich R. Inactivation of Orientia tsutsugamushi in red blood cells, plasma, and platelets with riboflavin and light, as demonstrated in an animal model. Transfusion. 2007;47:240-247.
Thèmes : Inactivation des pathogènes ; maj-2007-04
BTT Cardo LJ, Rentas FJ, Ketchum L, Salata J, Harman R, Melvin W, Weina PJ, Mendez J, Reddy H, Goodrich R. Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light. Vox Sang. 2006;90:85-91.
Thèmes : Parasites ; Inactivation des pathogènes ; maj-2006-03
BTT Fast LD, DiLeone G, Li J, Goodrich R. Functional inactivation of white blood cells by Mirasol treatment. Transfusion. 2006;46:642-648.
Thèmes : Techniques d'obtention des produits sanguins ; Inactivation des pathogènes ; maj-2006-06
BTT Fast LD, DiLeone G, Cardarelli G, Li J, Goodrich R. Mirasol PRT treatment of donor white blood cells prevents the development of xenogeneic graft-versus-host disease in Rag2-/-gamma c-/- double knockout mice. Transfusion. 2006;46:1553-1560.
Thèmes : Transplantation ; Inactivation des pathogènes ; maj-2006-12
BTT Roth K, Busch M, Cardoso M, Epstein J, Goodrich R, Hardiman A, Lelie N, Nübling M, Padilla A, Saldanha J, Schochetman G. Subgroup on virology of the ISBT transfusion-transmitted diseases working party. Transfus Today. 2006;n° 66:5.
Thèmes : Epidémiologie ; maj-2006-06
Document Pdf
BTT Perez-Pujol S, Tonda R, Lozano M, Fuste B, Lopez-Vilchez I, Galan AM, Li J, Goodrich R, Escolar G. Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates. Transfusion. 2005;45:911-919.
Thèmes : Produits sanguins plaquettaires ; Inactivation des pathogènes ; maj-2005-10